Diabetes: Add-on aliskiren has limited benefit
- PMID: 23165159
- DOI: 10.1038/nrendo.2012.221
Diabetes: Add-on aliskiren has limited benefit
Comment on
-
Cardiorenal end points in a trial of aliskiren for type 2 diabetes.N Engl J Med. 2012 Dec 6;367(23):2204-13. doi: 10.1056/NEJMoa1208799. Epub 2012 Nov 3. N Engl J Med. 2012. PMID: 23121378 Clinical Trial.
References
-
- N Engl J Med. 2012 Dec 6;367(23):2204-13 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
